$EVMN insider trading

Over the last 12 months, Evommune insiders reported 2 buys totaling $146K and 9 sales totaling $2.3M across SEC Form 4 filings. 82% of the activity was filed under pre-arranged 10b5-1 trading plans.

$146K
$2.3M
11
7
82%
Side
$10K$100K$1.0MMay '26JunJulAug
Cohen David E
Carver Kyle
Patel Jeegar Pravinkumar
Pena Luis C.
KIRSCH ARTHUR S

All insider trades

Jul 8, 2026Carver Kyle▲ Buy1,000$13.26$13K+1.7%
Jul 7, 2026KIRSCH ARTHUR S▲ Buy10,000$13.3$133K
Jun 22, 2026Drew Janice Suzann▼ Sale20,000$22.63$453K-22.8%
Jun 22, 2026Patel Jeegar Pravinkumar▼ Sale1,488$22.5$33K-3.1%
Jun 22, 2026Pena Luis C.▼ Sale7,438$22.71$169K-1.2%
Jun 2, 2026Cohen David E▼ Sale600$21.38$13K-3.3%
Jun 2, 2026Cohen David E▼ Sale5,456$20.21$110K-23.1%
Jun 1, 2026Patel Jeegar Pravinkumar▼ Sale16,687$22.74$379K-26.4%
Jun 1, 2026Pena Luis C.▼ Sale16,787$22.74$382K-2.6%
May 28, 2026Moss Gregory S.▼ Sale14,223$22.83$325K-18.9%
May 28, 2026Carver Kyle▼ Sale18,175$22.84$415K-23.4%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $EVMN feed.

EVMN Insider Trading — Form 4 Buys & Sells | alphai